Diagnostic Performance of Target-position Murray Law based Quantitative Flow Ratio (target-μFR) vs Vessel-μFR in Patients with stable Coronary Artery Disease

Author:

Huang Wenhao1,Liu Yajun1,Wang Qianqian1,Jin Hongfeng1,Tang Yiming1,Wang Jiangting1,Liu Xiaowei1,Guo Yitao1,Ye Chen1,Tang Lijiang1,Du Changqing1

Affiliation:

1. Zhejiang Hospital

Abstract

Abstract Background: We aim to compare with the diagnostic performance of target-position quantitative flow ratio derived from Murray Law (target-μFR) and vessel quantitative flow ratio derived from Murray Law (vessel-μFR) using the fractional flow reserve (FFR) as reference standard. This study may provide more evidence for the novel clinical usage of target-μFR in the diagnosis of coronary artery disease. Methods: Six hundreds and fifty-six patients (685 lesions) with known or suspected coronary artery disease were screened for this retrospective analysis between January 2021 to March 2023. A total of 161 patients (190 lesions) underwent quantitative coronary angiography and FFR evaluations. Both of target-μFR and vessel-μFR were compared the diagnostic performance using the FFR≤0.80 as the reference standard. Results: Both target-μFR (R=0.90) and vessel-μFR (R=0.87) demonstrated a strong correlation with FFR, and both methods showed great agreement with FFR. The area under the receiver operating characteristic curve was 0.937 for target-μFR and 0.936 for vessel-μFR in predicting FFR≤0.80. FFR≤0.80 were predicted with high sensitivity (92.98%), specificity (91.01%) and the Youden index (0.840) using the cutoff value of 0.83 for target-μFR. A good diagnostic performance (sensitivity 86.44%, specificity 88.51% and Youden index 0.750) was also demonstrated by vessel-μFR which the cutoff value was 0.80. Conclusion: The target-μFR has the similar diagnostic performance with vessel-μFR. The accuracy of μFR does not seem to be affected by the selection of the measurement point. Both of the virtual model could be used as computations tools for diagnosing ischemia and to aid clinical decision-making.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3